Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCEP +/- Thalidomide in Refractory Multiple Myeloma
NCT00005834Phase 3Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- Apr 2000
- Primary completion
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in multiple myeloma (MM), sponsored by SWOG Cancer Research Network. Started Apr 2000; status: terminated.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00005834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005834.